Viracta Therapeuticsincwas A Clinical Stage Precision Oncology Company Based In Cardiffcaliforniathe Company Focused On Developing Therapies For Virus Associated Cancersparticularly Those Linked To The Epstein Barr Virusebv Viracta Specialized In Targeting Latent Viral Infections In Cancer Cells Using A Proprietarykick & Killmechanismwhich Aimed To Reactivate Viral Genes And Induce Tumor Cell Death The Company S Product Portfolio Included Nana Valan Oral Combination Therapy For Relapsed Refractory Ebv Positive Lymphomas And Solid Tumorswhich Showed Activity In Clinical Trialsanother Assetvecabrutinibwas An Investigational Brutonae S Tyrosine Kinasebtkinhibitor Targeting Lymphoma And Chronic Lymphocytic Leukemiaviracta S Therapies Were Designed To Address The Needs Of Patients With Limited Treatment Options For Ebv Positive Cancersthe Company Announced Its Wind Down In Early 2025
No conferences found for this company.
| Company Name | Sunesis Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
